Ionis Pharmaceuticals, Inc. (IONS) vs TG Therapeutics, Inc. (TGTX)
A side-by-side comparison of Ionis Pharmaceuticals, Inc. and TG Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IONS
Ionis Pharmaceuticals, Inc.
$44.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TGTX
TG Therapeutics, Inc.
$52.19HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — IONS vs TGTX
growth of $100 · dividends reinvested · last 10yIONS +22.0% (+2.0%/yr)TGTX +540.3% (+20.4%/yr)TGTX compounded faster over this window
Log scale — wide-divergence pair
IONS TGTX
IONS vs TGTX: by the numbers
- •TGTX is the larger company ($7.99B vs $7.31B market cap).
- •TGTX is profitable (55.22% net margin) while IONS runs a net loss (-64.64%).
- •TGTX grew revenue faster over the past five years (219.22% vs 4.91% CAGR).
Metrics side by side
Valuation
| Metric | IONS | TGTX |
|---|---|---|
| P/E ratio | N/A | 19.05 |
| Forward P/E | N/A | 53.62 |
| P/S ratio | 8.37 | 9.99 |
| P/B ratio | 16.63 | 13.23 |
| EV / EBITDA | 2.21 | 60.46 |
| FCF yield | N/A | 0.22% |
Profitability
| Metric | IONS | TGTX |
|---|---|---|
| Gross margin | 98.16% | 82.36% |
| Operating margin | -40.47% | 17.05% |
| Net margin | -64.64% | 55.22% |
| ROE | -128.44% | 73.08% |
| ROIC | -20.37% | 9.94% |
Growth (annualized)
| Metric | IONS | TGTX |
|---|---|---|
| Revenue CAGR (5Y) | 4.91% | 219.22% |
| Total return CAGR (5Y) | 5.82% | 10.75% |
Frequently asked
- Which has grown faster, IONS or TGTX?
- Over the past five years, TGTX grew revenue faster — IONS at a 4.91% CAGR versus TGTX at 219.22%.
- Is IONS or TGTX more profitable?
- TGTX runs the higher net margin — IONS at -64.64% versus TGTX at 55.22%.
- How have IONS and TGTX total returns compared?
- Over the past 10 years, IONS delivered 1.80% and TGTX delivered 20.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
TG Therapeutics P/E ratioIonis Pharmaceuticals ROETG Therapeutics ROEIonis Pharmaceuticals operating marginTG Therapeutics operating marginIonis Pharmaceuticals revenue growthTG Therapeutics revenue growthIonis Pharmaceuticals free cash flowTG Therapeutics free cash flow
Ionis Pharmaceuticals & TG Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.